Back to video list Back to Home Eptinezumab – an efficacious, fast and sustained anti-CGRP monoclonal antibody therapy for preventive migraine treatment You may also like Depression Congress highlights Article Understanding the relationship between depression and heart disease to improve patient care Depression Schizophrenia Article ROAMER – continuing to push for mental health research Depression Article Somatic Symptoms of Depression and Its Treatment Schizophrenia Bipolar Article The Double Burden of Diabetes and Severe Mental Illness